| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $678K | -28.6% |
| R&D Expense | $294K | -43.0% |
| SG&A Expense | $132K | -40.8% |
| Operating Income | $219K | +73.3% |
| Interest Expense | $162K | -12.6% |
| Net Income | $4.5M | +7733.3% |
| EPS (Basic) | $0.01 | — |
| EPS (Diluted) | $0.01 | — |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $0 | -100.0% |
| Accounts Receivable | $0 | -100.0% |
| Current Assets | $0 | -100.0% |
| Total Assets | $7.2M | +89.3% |
| Current Liabilities | $1.5M | -14.7% |
| Long-term Debt | $25K | +0.0% |
| Total Liabilities | $2.5M | -31.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $331K | +1540.2% |
| Capital Expenditures | $0 | — |
| Investing Cash Flow | $0 | — |
| Financing Cash Flow | -$330K | -1282.6% |
| Free Cash Flow | $331K | +1540.2% |
| Stockholders' Equity |
| $4.7M |
| +2925.1% |